I do like this company, that's undeniable.
They are very good at many things, especially at issuing more shares.
Tassie may I ask for your opinion on a couple of matters?
- do you think the company should solely focus on its core offering - Cardiocel?
- should they remove / sell / divest from the medical pump businesses?
- should they use cash funds (currently large amounts on vaccines research), which may not sell a single vile on other areas of the business - such as extending the use of adapt or growing distribution of Cardiocel?
- should they distribute Cardiocel via Medical Distributers with establish networks in North America or fund it themselves?
If AHZ was solely an ADAPT/Cardiocel business, where do you think the share price would be...?
Article on news.com.au, page-12
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |